Veradermics, Incorporated
MANE
$98.86
-$4.98-4.79%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | |||
|---|---|---|---|---|---|
| Net Income | -50.22% | -119.61% | -285.99% | ||
| Total Depreciation and Amortization | -- | -- | -- | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | 1,036.76% | 939.89% | -30.74% | ||
| Change in Net Operating Assets | 1,405.98% | 117.01% | -408.18% | ||
| Cash from Operations | 7.37% | -58.95% | -550.55% | ||
| Capital Expenditure | -- | -- | -- | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | -3,228.52% | -543.95% | -- | ||
| Cash from Investing | -3,228.78% | -543.17% | -- | ||
| Total Debt Issued | -- | -- | -- | ||
| Total Debt Repaid | -- | -- | -- | ||
| Issuance of Common Stock | 321,278.29% | -- | -- | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -- | -- | 184.39% | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | -- | -- | -54.42% | ||
| Cash from Financing | 343,076.74% | 3,094.98% | 197.21% | ||
| Foreign Exchange rate Adjustments | -- | -- | -- | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | 732.95% | 810.36% | -65.49% | ||